Consortium on Modeling Autoimmune Diabetes (HIRN-CMAD)
|
CMAD is developing and optimizing in vitro and in vivo disease models that enable the study of human islet and immune interactions in type 1 diabetes (T1D). Active: December 2024 – present |
|
CMAD is developing and optimizing in vitro and in vivo disease models that enable the study of human islet and immune interactions in type 1 diabetes (T1D). Active: December 2024 – present |
Follow
